Glaukos Corporation
GKOS
Rang in aandelen
#2020
Glaukos Corporation operates as an ophthalmic medical technology and... Glaukos Corporation operates as an ophthalmic medical technology and pharmaceutical enterprise, primarily focused on pioneering novel therapies for glaucoma, corneal disorders, and retinal diseases. The company offers a range of micro-bypass stents, including iStent, iStent inject, and iStent inject W. These devices are designed to enhance aqueous humor outflow, being inserted during cataract surgery to treat mild-to-moderate open-angle glaucoma. Its promising product pipeline features iStent Infinite, a three-stent system intended for standalone use in patients with refractory glaucoma, as well as iDose TR, a targeted injectable implant that utilizes Glaukos's micro-scale device platform to deliver therapeutic levels of medication. The company distributes its products through a direct sales organization and a network of distributors, serving markets across the United States and internationally. Glaukos Corporation, founded in 1998, is headquartered in San Clemente, California.
Aandeelprijs
$174.03
Marktkapitalisatie
$10.26B
Verandering (1 dag)
4.34%
Verandering (1 jaar)
118.99%
Land
US
Handel Glaukos Corporation (GKOS)
Categorie
Healthcare
P/B-ratio voor Glaukos Corporation (GKOS)
P/B-ratio op October 2026 TTM: 14.37
Volgens de meest recente financiële rapporten en aandelenkoers van Glaukos Corporation is de huidige P/B-ratio (TTM) 14.37. Eind 2023 had het bedrijf een P/B-ratio van 8.34.
P/B-ratiohistoriek voor Glaukos Corporation van 2012 tot 2026
P/B-ratio aan het einde van elk jaar
| Jaar | P/B-ratio | Wijzigen |
|---|---|---|
| 2026 (TTM) | 14.37 | 39.39% |
| 2024 | 10.31 | 23.71% |
| 2023 | 8.34 | 113.23% |
| 2022 | 3.91 | 11.28% |
| 2021 | 3.51 | -29.97% |
| 2020 | 5.02 | 66.02% |
| 2019 | 3.02 | -73.28% |
| 2018 | 11.31 | 77.22% |
| 2017 | 6.38 | -33.74% |
| 2016 | 9.63 | 112.49% |
| 2015 | 4.53 | -188.26% |
| 2014 | -5.13 | -6.61% |
| 2013 | -5.50 | -74.41% |
| 2012 | -21.48 | 0.00% |
P/B-ratio voor vergelijkbare bedrijven of concurrenten
| Bedrijf | P/B-ratio | Verschil in P/B-ratio | Land |
|---|---|---|---|
| 3.5116 | -75.56% |
US
|
|
| 2.0146 | -85.98% |
IE
|
|
| 4.5025 | -68.67% |
US
|
|
| 2.5486 | -82.27% |
US
|
|
| - | - |
DE
|
